The Sheppard and Enoch Pratt Hospital, known to many simply as Sheppard Pratt, is a psychiatric hospital located in Towson, a northern suburb of Baltimore, Maryland. Founded in 1853, it is one of the oldest private psychiatric hospitals in the nation.

During the past decade, Sheppard Pratt Health System conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 16 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 7 clinical trials were completed. i.e. 87.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sheppard Pratt Health System" #1 sponsor was "Sheppard Pratt Health System" with 14 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "COMPASS Pathways" with 3 trials sponsored, "Naurex, Inc, an affiliate of Allergan plc" with 3 trials sponsored and "Neuronetics" with 3 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sheppard Pratt Health System" #1 collaborator was "Stanley Medical Research Institute" with 4 trials as a collaborator, "COMPASS Pathways" with 3 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 2 trials as a collaborator, "Otsuka America Pharmaceutical" with 2 trials as a collaborator and "Sheppard Pratt Health System" with 2 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Sheppard Pratt Health System" are "Schizophrenia" (12 trials), "Schizoaffective Disorder" (10 trials), "Depressive Disorder, Major" (7 trials), "Major Depressive Disorder" (6 trials) and "Treatment Resistant Depression" (5 trials). Many other conditions were trialed in "Sheppard Pratt Health System" in a lesser frequency.

Most popular intervention types in "Sheppard Pratt Health System" are "Drug" (33 trials), "Device" (8 trials), "Other" (4 trials), "Behavioral" (3 trials) and "Dietary Supplement" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Psilocybin" (6 trials), "Esketamine" (3 trials), "Inert Compound" (3 trials) and "Probiotic Supplement" (3 trials). Other intervention names were less common.

The vast majority of trials in "Sheppard Pratt Health System" are 47 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Sheppard Pratt Health System". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 29 completed trials in Sheppard Pratt Health System, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Sheppard Pratt Health System, 1 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 9 trials that are defined as “Not Applicable".